nonlinear regression model with variable slope graphpad prism Search Results


non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software
Non Linear Dose–Response Curve Fitting Analyses Via Graphpad Prism V. 2.01 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
log (agonist) versus normalized-response (variable slope) nonlinear regression model  (GraphPad Software Inc)
90
GraphPad Software Inc log (agonist) versus normalized-response (variable slope) nonlinear regression model
Log (Agonist) Versus Normalized Response (Variable Slope) Nonlinear Regression Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/log (agonist) versus normalized-response (variable slope) nonlinear regression model/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
log (agonist) versus normalized-response (variable slope) nonlinear regression model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nonlinear regression to a normalized variable slope model in graphpad prism 9  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear regression to a normalized variable slope model in graphpad prism 9
Nonlinear Regression To A Normalized Variable Slope Model In Graphpad Prism 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression to a normalized variable slope model in graphpad prism 9/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression to a normalized variable slope model in graphpad prism 9 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
prism 9 nonlinear regression fit modelling variable slope  (GraphPad Software Inc)
90
GraphPad Software Inc prism 9 nonlinear regression fit modelling variable slope
Prism 9 Nonlinear Regression Fit Modelling Variable Slope, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism 9 nonlinear regression fit modelling variable slope/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism 9 nonlinear regression fit modelling variable slope - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0  (GraphPad Software Inc)
90
GraphPad Software Inc curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Curves Generated From Raw Fluorescence Data Using A 4 Parameter Variable Slope Hill Model In Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nonlinear fit model with variable slope and normalized response  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear fit model with variable slope and normalized response
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Nonlinear Fit Model With Variable Slope And Normalized Response, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear fit model with variable slope and normalized response/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear fit model with variable slope and normalized response - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear regression, with variable slope sigmoidal curve fitting model  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression, with variable slope sigmoidal curve fitting model
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Non Linear Regression, With Variable Slope Sigmoidal Curve Fitting Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression, with variable slope sigmoidal curve fitting model/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression, with variable slope sigmoidal curve fitting model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
log (inhibitor) vs. normalized response-variable slope in graphpad prism version 9.5.0  (GraphPad Software Inc)
90
GraphPad Software Inc log (inhibitor) vs. normalized response-variable slope in graphpad prism version 9.5.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Log (Inhibitor) Vs. Normalized Response Variable Slope In Graphpad Prism Version 9.5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/log (inhibitor) vs. normalized response-variable slope in graphpad prism version 9.5.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
log (inhibitor) vs. normalized response-variable slope in graphpad prism version 9.5.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sigmoidal concentration response model with variable slope by graphpad prism 8.0  (GraphPad Software Inc)
90
GraphPad Software Inc sigmoidal concentration response model with variable slope by graphpad prism 8.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Sigmoidal Concentration Response Model With Variable Slope By Graphpad Prism 8.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sigmoidal concentration response model with variable slope by graphpad prism 8.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
sigmoidal concentration response model with variable slope by graphpad prism 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
concentration–response relations fit with a variable slope model graphpad prism v.6.02  (GraphPad Software Inc)
90
GraphPad Software Inc concentration–response relations fit with a variable slope model graphpad prism v.6.02
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Concentration–Response Relations Fit With A Variable Slope Model Graphpad Prism V.6.02, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/concentration–response relations fit with a variable slope model graphpad prism v.6.02/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
concentration–response relations fit with a variable slope model graphpad prism v.6.02 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
non-linear regression to a normalized variable slope model in graphpad v9 (prism)  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression to a normalized variable slope model in graphpad v9 (prism)
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Non Linear Regression To A Normalized Variable Slope Model In Graphpad V9 (Prism), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression to a normalized variable slope model in graphpad v9 (prism)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression to a normalized variable slope model in graphpad v9 (prism) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
normalised response, variable slope, dose–response model prism 8.0  (GraphPad Software Inc)
90
GraphPad Software Inc normalised response, variable slope, dose–response model prism 8.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Normalised Response, Variable Slope, Dose–Response Model Prism 8.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normalised response, variable slope, dose–response model prism 8.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
normalised response, variable slope, dose–response model prism 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.

Journal: Toxicological Sciences

Article Title: Nonionic Ethoxylated Surfactants Induce Adipogenesis in 3T3-L1 Cells

doi: 10.1093/toxsci/kfx234

Figure Lengend Snippet: Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.

Article Snippet: EC20/50 values were estimated using curves generated from raw fluorescence data using a 4-parameter variable-slope Hill model in GraphPad Prism 7.0.

Techniques: Inhibition, Activity Assay, Reporter Gene Assay, Reporter Assay, Positive Control, Intra Assay, Concentration Assay